Moderna GAAP EPS of $0.19 beats by $1.94, revenue of $1.9B beats by $730M
Moderna press release  (NASDAQ:MRNA): Q1  GAAP EPS of $0.19  beats by $1.94.
Revenue of $1.9B (-68.9% Y/Y)  beats by $730M.
Product sales for the first quarter of 2023 were $1.8 billion, a decrease of 69%, compared to the same period in 2022, primarily driven by lower sales volume.
The Company continues to expect to make capital investments for 2023 of approximately $1.0 billion.